How is hyponatremia treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hyponatremia Based on Volume Status and Severity

The treatment of hyponatremia should be guided by the patient's volume status (hypovolemic, euvolemic, or hypervolemic) and symptom severity, with correction rates carefully monitored to prevent neurological complications. 1

Initial Assessment

Volume Status Determination

  • Hypovolemic: Orthostatic hypotension, dry mucous membranes, urine Na <20 mEq/L
  • Euvolemic: Normal vital signs, no edema, urine Na >20-40 mEq/L
  • Hypervolemic: Edema, ascites, elevated JVP, urine Na <20 mEq/L 1

Symptom Severity Classification

  • Severe symptoms: Mental status changes, seizures, coma
  • Mild symptoms: Nausea, vomiting, headache, weakness
  • Asymptomatic: No clinical manifestations 2

Treatment Algorithm by Volume Status

1. Hypovolemic Hyponatremia

  • Primary treatment: Isotonic (0.9%) saline to restore volume 1
  • Monitoring: Check serum sodium every 2-4 hours initially during correction 1
  • Goal: Address underlying cause (e.g., GI losses, diuretics) 3

2. Euvolemic Hyponatremia (e.g., SIADH)

  • First-line: Fluid restriction (1-1.5 L/day) 1
  • If severe symptoms present:
    • 3% hypertonic saline (100-150 mL bolus or continuous infusion) 4
    • Correct 6 mEq/L in first 6 hours or until severe symptoms resolve 2
  • Second-line options (if fluid restriction fails):
    • Tolvaptan starting at 15 mg once daily (for short-term ≤30 days) 5
    • Oral urea 4
    • Salt tablets 6

3. Hypervolemic Hyponatremia (e.g., heart failure, cirrhosis)

  • Primary approach: Fluid restriction to 1,000 mL/day 1
  • Pharmacologic options:
    • Loop diuretics 7
    • Albumin infusion for severe cases 1
    • Tolvaptan (with careful monitoring) 5

Correction Rate Guidelines

  • Severe symptomatic hyponatremia: Increase Na by 1-2 mEq/L per hour until symptoms abate 7
  • Maximum correction limits:
    • 8 mEq/L in 24 hours 2
    • 18 mEq/L in 48 hours 7
  • High-risk patients: Limit correction to 4-6 mEq/L per day 1

Special Considerations

Cerebral Salt Wasting (CSW)

  • Treatment: Aggressive volume resuscitation with sodium and fluid replacement 1
  • Pharmacologic option: Fludrocortisone 0.1-0.2 mg three times daily 1
  • Monitoring: Central venous pressure (CVP <6 cm H₂O suggests CSW) 1

Subarachnoid Hemorrhage Patients

  • Treatment threshold: Even for serum Na 131-135 mEq/L 2
  • Approach: More aggressive volume resuscitation to prevent vasospasm 1

Complications to Monitor

  • Osmotic demyelination syndrome: Risk increases with overly rapid correction (>12 mEq/L per 24 hours) 7
  • Symptoms of overcorrection: Parkinsonism, quadriparesis 3
  • Prevention: Frequent monitoring (every 2-4 hours initially) and adjustment of treatment 1

Pitfalls to Avoid

  • Misdiagnosis of volume status: Incorrectly treating SIADH with saline or CSW with fluid restriction can worsen hyponatremia 2
  • Inadequate monitoring: Failure to check sodium levels frequently during active correction 1
  • Excessive correction: Particularly dangerous in chronic hyponatremia (>48 hours duration) 8
  • Undertreating severe symptoms: Delaying hypertonic saline in patients with seizures or altered mental status 3

By following this structured approach based on volume status and symptom severity, clinicians can effectively manage hyponatremia while minimizing the risk of complications.

References

Guideline

Hyponatremia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Research

The treatment of severe hyponatremia.

Kidney international. Supplement, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.